These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats. Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941 [TBL] [Abstract][Full Text] [Related]
3. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653 [TBL] [Abstract][Full Text] [Related]
5. Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein. Couser WG; Stilmant MM; Darby C Lab Invest; 1976 Jan; 34(1):23-30. PubMed ID: 1246122 [TBL] [Abstract][Full Text] [Related]
6. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat. Adler S; Baker P; Pritzl P; Couser WG J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of sequential glomerular eluates from rats with Heymann nephritis. Abrass CK J Immunol; 1986 Jul; 137(2):530-5. PubMed ID: 3487574 [TBL] [Abstract][Full Text] [Related]
8. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis. Makker SP; Tramontano A J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232 [TBL] [Abstract][Full Text] [Related]
9. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat. Weening JJ; Grond J; Hoedemaeker PJ Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777 [TBL] [Abstract][Full Text] [Related]
10. Interaction of antibodies with human glomerular epithelial cells. Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288 [TBL] [Abstract][Full Text] [Related]
11. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Susani M; Schulze M; Exner M; Kerjaschki D Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis. Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201 [TBL] [Abstract][Full Text] [Related]
14. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108. Natori Y; Hayakawa I; Shibata S Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192 [TBL] [Abstract][Full Text] [Related]
15. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells. Camussi G; Salvidio G; Biesecker G; Brentjens J; Andres G J Immunol; 1987 Nov; 139(9):2906-14. PubMed ID: 3312408 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease. Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141 [TBL] [Abstract][Full Text] [Related]
17. Progressive passive Heymann nephritis in the rat. Barabas AZ; Boyd N; Cornish J; Lannigan R Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666 [TBL] [Abstract][Full Text] [Related]
18. The specificity of nephritogenic antibodies. V. Glomerular localization of anti-GP 330 and anti-GP 90 antibodies present in passive Heymann serum. Bagchus WM; Hoedemaeker PJ; Slegers JF; Bakker WW Br J Exp Pathol; 1988 Dec; 69(6):855-64. PubMed ID: 3064801 [TBL] [Abstract][Full Text] [Related]
19. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes. Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850 [TBL] [Abstract][Full Text] [Related]
20. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. Salant DJ; Darby C; Couser WG J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]